Drug To Treat Peanut Allergies in Children


A Creative Commons picture by USDAgov

More than 3 million people in the United States report having an allergy to peanuts, tree nuts, or both according to statistics from the American Allergy Asthma & Immunology.

The US Food and Drug Administration approved the first drug to treat peanut allergies.

According to CNN, “The drug, Palforzia, can be used for children between ages 4 and 17 years old. It’s designed to minimize the incidence and severity of a child’s allergic reaction to peanuts, as even a small amount of exposure can be harmful to children with the allergy.”

The use of Palforzia is supposed to reduce the allergic reaction to peanuts, but exposure to peanuts will still need to be avoided. Palforzia is an FDA- approved treatment to reduce risk of allergic reaction in children with a peanut allergy.

The Palforzia treatment basically works by exposing children (patients) to controlled dosages of peanut protein until they reach a maintenance level. During treatment Anaphylaxis can occur anytime, but is more at risk during and after the initial dose of each up-dosing level.

Anaphylaxis is a severe, potentially life-threatening allergic reaction. Doses are administered under supervision in a healthcare setting and monitor reactions. Palforzia comes in powder, which is made from actual peanuts, and should be mixed with semi-solid food like yogurt according to CNN.

According to CNN, “Provider’s will also have to counsel patients or caregivers to have an injectable epinephrine (Chemical that narrows blood vessels and opens lungs airways) drug with them that can be ready to be used at all times.”